Article Information
- November 13, 2020.
Author Information
- H.E. Baxendale*,1,
- D. Wells2,
- J. Gronlund1,
- A. Nadesalingam2,
- M. Paloniemi2,
- G. Carnell2,
- P. Tonks2,
- L. Ceron-Gutierrez6,
- S. Ebrahimi6,
- A. Sayer6,
- J.A.G. Briggs3,
- X. Xiong3,
- J.A. Nathan4,
- G.L. Grice4,
- L.C. James5,
- J. Luptak5,
- S. Pai1,
- J.L. Heeney2 and
- R. Doffinger6
- 1Royal Papworth NHS Trust, Cambridge, CB2 0AY, United Kingdom
- 2Laboratory of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, United Kingdom
- 3Structural Studies Division, Medical Research Council Laboratory of Molecular Biology, Cambridge, CB2 0QH, United Kingdom
- 4Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), University of Cambridge, Cambridge, United Kingdom
- 5Protein and Nucleic Acid Chemistry Division, Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 0QH, United Kingdom
- 6Department of Clinical Biochemistry and Immunology, Addenbrooke’s Hospital, Cambridge, UK
- ↵*Correspondence to: HEB: hbaxendale{at}nhs.net
Author Contributions: HEB and JLH conceived the project and planned the study. HEB secured ethical approval. HEB DW and JLH secured funding. Recruitment of participants, data management and sera collection were performed by HEB and JG. Sera processing was performed by RD, AN, MP, PT and GC. JAGB, XX, JAN, GLG, LCJ and JL generated and provided the SARS-CoV-2 proteins to support RD in establishing and validating the luminex platform. RD, AS, LC-G and SE analysed the sera by luminex and reported the results. HEB, DW and RD analysed the data. HEB generated the tables; RD and DW generated the Figures. DW ran the statistical analysis. HEB, DW and RD wrote the manuscript with contribution from all authors.
Competing interests: The authors have no competing interests.